BCL2 and cancer: Under normal conditions, apoptosis allows for the elimination of damaged or unnecessary cells, but in cancers, the mechanisms of this pathway are deactivated, often through mutations in genes encoding proteins such as Bcl-2, Bax, or caspases (described in Section 2).